From the content of Diversity Action Plans to the nuances of submission, implementation, and monitoring for inclusive and representative research, the...
Though the life sciences industry has committed to improving diversity in clinical trials, there’s still work to be done. Childhood asthma is a case i...
Earlier this year, the U.S. Food and Drug Administration updated its guidance document on collecting race and ethnicity data in clinical trials. The d...
Under 2022’s Food and Drug Omnibus Reform Act, clinical trial sponsors are required tosubmit diversity action plans with pivotal drug studies such as ...
Clinical research requires trust between the patient and the pharmaceutical companies. When that trust has been damaged, patients will avoid participa...
Inclusive clinical research populations are necessary for a successful study, and new laws are beginning to mandate diversity action plans to promote ...
As we celebrate our four-year anniversary, Acclinate stands at the forefront of a crucial revolution in healthcare—empowering communities of color to ...
When Marques Bradley joined Acclinate amidst the pandemic's uncertainty in October of 2020, it wasn't just another job opportunity; it was a call to m...
Your clinical research processes are carefully developed over the years, and the success of your project depends on thoughtful preparation. As pharmac...
